文献速递技术与安全CT

碘帕醇作为CT口服对比剂:与碘海醇、泛影酸钠及硫酸钡的口感比较

Iopamidol as an oral contrast media for computed tomography: a taste comparison to iohexol, diatrizoate sodium, and barium sulfate.
PubMed 文献 · Abdom Radiol (NY) · 2017-01-01

本研究为盲法随机试验,50名健康受试者品尝碘帕醇、碘海醇、泛影葡胺与泛影酸钠溶液及2.1% w/v硫酸钡混悬液并评分。碘帕醇与碘海醇口感无显著差异,泛影葡胺与泛影酸钠溶液显著不如硫酸钡和碘海醇受欢迎。

要点

  • 碘帕醇与碘海醇口服口感评分无显著差异(p=.959)。
  • 泛影葡胺与泛影酸钠溶液口感显著低于硫酸钡(p=.000)和碘海醇(p=.012)。
  • 碘帕醇、碘海醇与硫酸钡三组间口感均值无显著差异(p=.174)。

核心结论

  • 碘帕醇与碘海醇口感无显著差异,支持碘帕醇作为碘海醇的可行替代口服对比剂。

研究设计与样本

  • 盲法随机试验,50名健康受试者品尝四种口服对比剂并评分,评分采用0至40连续尺度。

诊断标准与关键数值

  • 口感评分尺度:0=不可耐受,10=不愉快但可耐受,20=中性,30=有点喜欢,40=非常喜欢。
  • 平均评分(标准差/标准误,n=50):碘帕醇21.0(8.4/1.2);碘海醇21.8(7.1/1.0);泛影葡胺与泛影酸钠溶液16.8(9.6/1.4);硫酸钡23.7(9.1/1.3)。
  • 单因素方差分析示各组均值不等(F*=6.550,p=.000);事后检验示泛影葡胺与泛影酸钠溶液显著低于硫酸钡(p=.000)和碘海醇(p=.012)。
  • 碘帕醇与碘海醇比较无差异(p=.959);仅碘帕醇、碘海醇与硫酸钡三组比较未拒绝均值相等假设(F*=1.778,p=.174)。

临床应用与阅片要点

  • 作者认为碘帕醇可作为碘海醇的可行替代口服对比剂。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The objective of this study is to compare the palatability of iopamidol and iohexol.

METHODS: This was a blinded and randomized trial in which fifty healthy subjects taste tested iopamidol (Isovue, Bracco Diagnostics), iohexol (Omnipaque, GE Healthcare), diatrizoate meglumine and diatrizoate sodium solution (Gastrografin, Bracco Diagnostics), and barium sulfate suspension 2.1% w/v, 2.0% w/w (READI-CAT2, E-Z-EM). Participants scored palatability on a continuous scale from 0 to 40 (0 = intolerable, 10 = unpleasant but tolerable, 20 = neutral, 30 = kind of like, 40 = strongly like).

RESULTS: Mean scores (SD/SEM) for the contrast agents (n = 50) were iopamidol = 21.0 (8.4/1.2); iohexol = 21.8 (7.1/1.0); Gastrografin = 16.8 (9.6/1.4); and barium = 23.7 (9.1/1.3). One-way ANOVA equality of means test shows rejection of the hypothesis that the means are equal (F* = 6.550, p = .000). Post hoc testing demonstrates Gastrografin to be significantly less preferred to barium (p = .000) and iohexol (p = .012). No difference was found between iopamidol and iohexol (p = .959). One-way ANOVA equality of means test of just iopamidol, iohexol, and barium does not reject the hypothesis that means are equal (F* = 1.778 and p = .174).

CONCLUSION: There is no significant difference in palatability between iopamidol and iohexol, supporting the use of iopamidol as a viable alternative to iohexol as an oral contrast agent.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Rogers D, Sheth C, Eisenmenger L, et al. Iopamidol as an oral contrast media for computed tomography: a taste comparison to iohexol, diatrizoate sodium, and barium sulfate. Abdom Radiol (NY). 2017. PMID: 28669111. doi:10.1007/s00261-017-1226-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。